IL17A and asthma: Previous experimental research revealed beneficial effects of anti-Il-17 in LPS exacerbated asthma in murine models [1,2,3,4] and an alleviation of ALI inflammation [21], possibly by reducing the expression of cytokines and oxidative stress [5].